Search

Your search keyword '"Tugcu, G."' showing total 35 results

Search Constraints

Start Over You searched for: Author "Tugcu, G." Remove constraint Author: "Tugcu, G."
35 results on '"Tugcu, G."'

Search Results

2. Read-across for regulatory ecotoxicology

3. Do We Build Similar Molecules for Comorbid Diseases? Tevarud in Drug Design, an Analysis for Depression and Inflammation

4. Flexible Bronchoscopy Findings in Children with Congenital Lobar Emphysema: 8-Year Data from a Single Center Study

6. P311 Clinical features of cystic fibrosis patients with chronic liver disease in the Turkish National Cystic Fibrosis Registry

7. P323 Pseudo Bartter Syndrome: the most common complication in the Turkish National Cystic Fibrosis Registry

10. P059 First results of Turkish National Cystic Fibrosis Registry

15. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents

16. A QSAR Study for Analgesic and Anti-inflammatory Activities of 5-/6-Acyl-3-alkyl-2-Benzoxazolinone Derivatives

17. Toxicological assessment of epinephrine and norepinephrine by analog approach

18. Cheminformatics and Machine Learning Approaches to Assess Aquatic Toxicity Profiles of Fullerene Derivatives.

19. Increased Plasma YKL-40 Level and Chitotriosidase Activity in Cystic Fibrosis Patients.

20. How fullerene derivatives (FDs) act on therapeutically important targets associated with diabetic diseases.

21. Toxicological evaluation of ergocalciferol, cholecalciferol, and their metabolites by a category approach.

22. Filling data gap for nicotinic acid, nicotinate esters and nicotinamide for the determination of permitted daily exposure by a category approach.

23. The integrated use of in silico methods for the hepatotoxicity potential of Piper methysticum.

24. Clinical features and accompanying findings of Pseudo-Bartter Syndrome in cystic fibrosis.

25. Respiratory viruses: What is their role in acute exacerbations in children with cystic fibrosis?

26. Plasma Ceramides and Sphingomyelins of Pediatric Patients Increase in Primary Ciliary Dyskinesia but Decrease in Cystic Fibrosis.

27. Do We Build Similar Molecules for Comorbid Diseases? Tevarud in Drug Design, an Analysis for Depression and Inflammation.

28. QSPR modelling of in vitro degradation half-life of acyl glucuronides.

29. A QSAR Study for Analgesic and Anti-inflammatory Activities of 5-/6-Acyl-3-alkyl-2-Benzoxazolinone Derivatives.

30. Application of a Validated QSTR Model for Repurposing COX-2 Inhibitor Coumarin Derivatives as Potential Antitumor Agents.

31. Toxicological assessment of epinephrine and norepinephrine by analog approach.

32. A multipronged QSAR approach to predict algal low-toxic-effect concentrations of substituted phenols and anilines.

33. On the aquatic toxicity of substituted phenols to Chlorella vulgaris: QSTR with an extended novel data set and interspecies models.

34. Actual drug allergy during childhood: Five years' experience at a tertiary referral centre.

35. Comparative performance of descriptors in a multiple linear and Kriging models: a case study on the acute toxicity of organic chemicals to algae.

Catalog

Books, media, physical & digital resources